News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Medline (NASDAQ:MDLN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $55.00 price target on the stock.

Medline to report fourth quarter and full year 2025 results on February 25, 2026

Baillie Gifford's Strategic Moves: Cloudflare Inc. Reduction by 23% [Yahoo! Finance]

Medline (NASDAQ:MDLN) was given a new $55.00 price target on by analysts at JPMorgan Chase & Co..

Medline (NASDAQ:MDLN) had its "buy" rating reaffirmed by analysts at BTIG Research.

Form 3 Medline Inc. For: Jan 16 Filed by: BX Mozart ML-2 Holdco GP L.L.C.

Form 4 Medline Inc. For: Jan 16 Filed by: CP VII Circle AIF Holdings, S.C.Sp.

Form 4 Medline Inc. For: Jan 16 Filed by: TC Group VII S1, L.L.C.

Form 4 Medline Inc. For: Jan 16 Filed by: Carlyle Mozart Coinvestment Holdings, L.P.

Form 3 Medline Inc. For: Jan 16 Filed by: CP Circle ML-3 Holdco, L.P.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}